The effect of the spin trapping agent α-phenyl-n-tert-butyl nitrone on dexfenfluramine-induced serotonin depletion in rat brain

Environmental Toxicology and Pharmacology

Volumn 3, Issue 4, 1997, Pages 289-295

  Bergami, A ^a   Fracasso, C ^a   Caccia, S ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Phenyl tert butyl nitrone interaction; Dexfenfluramine; Drug brain concentration; p Chloroamphetamine; Rat; Serotonin

Indexed keywords

CHLORAMPHETAMINE; DEXFENFLURAMINE; N TERT BUTYL ALPHA PHENYLNITRONE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SPIN TRAPPING;

EID: 0030815076     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(97)00029-X     Document Type: Article

References (27)

1. Anelli, M., Fracasso, C., Bergami, A., Ferrarese, A., Garattini, S., Caccia, S., 1995. Effect of D-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes. Psychopharmacology (Berlin) 118, 188.
2. Bergami, A., Fracasso, C., Garattini, S., Caccia, S., 1995. Brain uptake and acute indole-depleting effect of dexfenfluramine in squirrel monkeys after a high-dose regimen. Pharm. Sci. 1, 45.
3. Caccia, S., Anelli, M., Ferrarese, A., Fracasso, C., Garattini, S., 1993. The role of D-norfenfluramine in the indole-depleting effect of D-fenfluramine in the rat. Eur. J. Pharmacol. 233, 71.
4. Caccia, S., Sarati, S., Anelli, M., Garattini, S., 1992. Effect of escalating doses of D-fenfluramine on the content of indoles in brain. Neuropharmacology 31, 875.
5. Cao, X., Phillis, J.W., 1994. α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644, 267.
6. Che, S., Johnson, M., Hanson, G.R., Gibb, J.W., 1995. Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur. J. Pharmacol. 293, 447.
7. Chen, G., Griffin, M., Poyer, J.L., McCay, P.B., 1990. HPLC procedure for the pharmacokinetic study of the spin-trapping agent, α-phenyl-N-tert-butyl nitrone (PBN). Free Rad. Biol. Med. 8, 93.
8. Chu, T., Kumagai, Y., DiStefano, E.W., Cho, A.K., 1996. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem. Pharmacol. 51, 789.
9. Colado, M.I., Green, A.R., 1995. The spin trap reagent α-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones. Eur. J. Pharmacol. 280, 343.
10. Colado, M.I., Murray, T.K., Green, A.R., 1993. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine adminstration and effects of chlormethiazole and dizocilpine. Br. J. Pharmacol. 108, 583.
11. Colado, M.I., Williams, J.L., Green, A.R., 1995. The hypertermic and neurotoxic effects of 'ecstasy' (MDMA) and 3,4-methylene-dioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the YP2D6 poor metabolizer phenotype. Br. J. Pharmacol. 115, 1281.
12. Commins, D.L., Axt, K.J., Vosmer, G., Seiden, L.S., 1987. 5,6-Dihydroxytryptamine, a serotonergic neurotoxin is formed endogenously in the rat brain. Brain Res. 403, 7.
13. Farfel, G.M., Seiden, L.S., 1995a. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramune, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 272, 868.
14. Farfel, G.M., Seiden, L.S., 1995b. Role of hypothermia in the mechanism of protection against serotogenic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS19755 and NBQX. J. Pharmacol. Exp. Ther. 272, 860.
15. Fracasso, C., Guiso, G., Confalonieri, S., Bergami, A., Garattini, S., Caccia, S., 1995. Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse - a comparison with the rat. Neuropharmacology 34, 1653.
16. Hiramatsu, M., Kumagai, Y., Unger, S.E., Cho, A.K., 1990. Metabolism of methylenedioxymethamphetamine: Formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 254, 521.
17. Invernizzi, R., Berettera, C., Garattini, S., Samanin, R., 1986. D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur. J. Pharmacol. 120, 9.
18. Invernizzi, R., Fracasso, C., Caccia, S., Di Clemente, A., Garattini, S., Samanin, R., 1989. Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and D-fenfluramine in rats. Relation to brain drug concentrations. Eur. J. Pharmacol. 163, 77.
19. Kleven, M.S., Seiden, L.S., 1989. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res. 505, 351.
20. McCann, U., Hatzidimitriou, G., Ridenour, A., Fischer, C., Yuan, J., Katz, J., Ricaurte, G., 1994. Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. J. Pharmacol. Exp. Ther. 269, 792.
21. Miller, D.B., O'Callaghan, J.P., 1994. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 752.
22. Murray, T.K., Williams, J.L., Misra, A., Colado, M.I., Green, A.R., 1997. The spin trap reagent PBN attenuates degeneration of 5-HT neurons in rat brain induced by p-chloroamphetamine but not fenfluramine. Neuropharmacology 35, 1615.
23. Rowland, N.E., Souquet, A.-M., Edwards, D.J., 1990. Long term actions of dexfenfluramine on food intake, body weight and brain serotonin in rodents. In: Paoletti, R., Vanhoutte, P.M., Brunello, N., Maggi, F.M. (Eds.), Serotonin: From Cell Biology to Pharmacology and Therapeutics. Kluwer Academic, Dordrecht, p. 631.
24. Sabol, K.E., Richards, J.B., Seiden, L.S., 1992. The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine. Brain Res. 582, 129.
25. Schmidt, C.J., Black, C.K., Taylor, V.L., 1991. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloro amphetamine or methamphetamine to rats. Eur. J. Pharmacol. 203, 41.
26. Stone, D.M., Johnson, M., Hanson, G.R., Gibb, J.W., 1989. Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur. J. Pharmacol. 172, 93.
27. Yue, T.-L., Gu, J.-L., Lysko, P.G., Cheng, H.-Y., Barone, F.C., Feuerstein, G., 1992. Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res. 574, 193.